Profound hearing loss from intravertebral artery cisplatin.
Wetmore
S J
SJ
Department of Otolaryngology-Head and Neck Surgery, West Virginia University School of Medicine, Robert C. Byrd Health Sciences Center, Morgantown 26506-9200, USA.
Koike
K J
KJ
Bloomfield
S M
SM
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D001254:Astrocytoma / Q000188:drug therapy* / Q000473:pathology; D001301:Audiometry, Pure-Tone; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009778:Occipital Lobe / Q000473:pathology; D014711:Vertebral Artery
D000970:Antineoplastic Agents; D002945:Cisplatin